These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 16159732)
1. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732 [TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. He Z; Lu C; Basra MK; Ou A; Yan Y; Li L J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712 [TBL] [Abstract][Full Text] [Related]
3. [Assessment on the reliability and validity of the Dermatology Life Quality Index in Chinese version]. Wang XL; Zhao TE; Zhang XQ Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):791-3. PubMed ID: 15555362 [TBL] [Abstract][Full Text] [Related]
4. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients. Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558 [TBL] [Abstract][Full Text] [Related]
5. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Basra MK; Sue-Ho R; Finlay AY Br J Dermatol; 2007 Mar; 156(3):528-38. PubMed ID: 17300244 [TBL] [Abstract][Full Text] [Related]
6. Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). Basra MK; Edmunds O; Salek MS; Finlay AY J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):813-21. PubMed ID: 18312324 [TBL] [Abstract][Full Text] [Related]
7. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D; Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884 [TBL] [Abstract][Full Text] [Related]
8. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. Katugampola RP; Hongbo Y; Finlay AY Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990 [TBL] [Abstract][Full Text] [Related]
9. Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne. Takahashi N; Suzukamo Y; Nakamura M; Miyachi Y; Green J; Ohya Y; Finlay AY; Fukuhara S; Health Qual Life Outcomes; 2006 Aug; 4():46. PubMed ID: 16884543 [TBL] [Abstract][Full Text] [Related]
10. The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients. Nijsten T; Sampogna F; Stern RS; Abeni D Dermatology; 2007; 215(4):348-51. PubMed ID: 17911994 [TBL] [Abstract][Full Text] [Related]
11. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D; Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804 [TBL] [Abstract][Full Text] [Related]
12. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index. Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573 [TBL] [Abstract][Full Text] [Related]
13. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. Hahn HB; Melfi CA; Chuang TY; Lewis CW; Gonin R; Hanna MP; Farmer ER J Am Acad Dermatol; 2001 Jul; 45(1):44-8. PubMed ID: 11423833 [TBL] [Abstract][Full Text] [Related]
14. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Inanir I; Aydemir O; Gündüz K; Danaci AE; Türel A Int J Dermatol; 2006 Mar; 45(3):234-8. PubMed ID: 16533221 [TBL] [Abstract][Full Text] [Related]
15. Sustained improvement of the quality of life of patients with psoriasis after hospitalization. Vensel E; Hilley T; Trent J; Taylor JR; Kirsner RS; Kerdel FA; Taylor JR; Schwartzberg JB J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):858-60. PubMed ID: 11050595 [TBL] [Abstract][Full Text] [Related]
16. Dermatology quality of life scales--a measure of the impact of skin diseases. Morgan M; McCreedy R; Simpson J; Hay RJ Br J Dermatol; 1997 Feb; 136(2):202-6. PubMed ID: 9068732 [TBL] [Abstract][Full Text] [Related]
17. The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis. Eghlileb AM; Basra MK; Finlay AY Dermatology; 2009; 219(1):63-70. PubMed ID: 19295185 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis. Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951 [TBL] [Abstract][Full Text] [Related]
19. Psoriasis has a major secondary impact on the lives of family members and partners. Eghlileb AM; Davies EE; Finlay AY Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044 [TBL] [Abstract][Full Text] [Related]
20. Quality of life instrument for Turkish people with skin diseases. Gurel MS; Yanik M; Simsek Z; Kati M; Karaman A Int J Dermatol; 2005 Nov; 44(11):933-8. PubMed ID: 16336527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]